---
title: "Clinical Experience"
---


<a href="Project_Experience.pdf#" class="download" title="Download Project Experience as PDF">Download Project Experience</a>			


## Oncology

|     Nr.    |     Condition   or disease                                                                                                                                          |     Phase          |     Site                         |
|------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------|----------------------------------|
| 1          |     [Selected advanced/metastatic solid tumors](https://clinicaltrials.gov/ct2/show/NCT04234113)                                                                    |     Phase   1      |     12   Sites                   |
| 2          |     [Acute Myeloid Leukemia](https://clinicaltrials.gov/ct2/show/NCT03516760)                                                                                       |     Phase   1      |     7   Sites                    |
| 3          |     [Non-small Cell Lung Cancer     Prostate Cancer     Renal Cancer     Transitional Cell Carcinoma](https://clinicaltrials.gov/ct2/show/NCT03927573)              |     Phase   1/2    |     5   Sites                    |
| 4          |     [Locally Advanced Unresectable Pancreatic Adenocarcinoma](https://www.clinicaltrials.gov/ct2/show/NCT04098432)                                                  |     Phase   1      |     4   Sites                    |
| 5          |     [AML and MDS patients failing or being refractory to   hypomethylating agent (HMA)-based treatment](https://classic.clinicaltrials.gov/ct2/show/NCT05583552)    |     Phase   2      |     12   Sites                   |
| 6          |     [Triple Negative Breast Cancer](https://clinicaltrials.gov/ct2/show/NCT02032277)                                                                                |     Phase   2      |     158   Sites                  |
| 7          |     [Breast Cancer](https://clinicaltrials.gov/ct2/show/NCT02682693?term=GeparX&draw=2&rank=1)                                                                      |     Phase   2      |     Multiple in Germany          |
| 8          |     [Breast Cance](https://clinicaltrials.gov/ct2/show/NCT02685059?term=GeparNuevo&draw=2&rank=1)                                                                   |     Phase   2      |     Multiple in Germany          |
| 9          |     [Cutaneous melanoma](https://www.melagenix.info/about-melagenix)                                                                                                |     Phase   3      |     Multiple in US and Europe    |
| 10         |     [Stage I-III melanoma](https://www.melagenix.info/for-healthcare-professionals)                                                                                 |     Phase   3      |     Multiple                     |
| 11         |     [Cervical Intraepithelial Neoplasia Grade 2/3](https://clinicaltrials.gov/ct2/show/NCT04484415)                                                                 |     Phase   3      |     Multiple in China            |
| 12         |     [Breast Cancer](https://clinicaltrials.gov/ct2/show/NCT01864746)                                                                                                |     Phase   3      |     11 Sites                     |
| 13         |     [Breast Cancer](https://clinicaltrials.gov/ct2/show/NCT02125344?term=GeparOcto&draw=2&rank=1)                                                                   |     Phase   3      |     Multiple in Germany          |
| 14         |     [Multiple Solid Tumor](https://classic.clinicaltrials.gov/ct2/show/NCT03993873)                                                                                 |     Phase   2      |     24 Sites                     |
